- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Eris Lifesciences Limited has successfully closed the acquisition of a 30% equity stake in Levim Lifetech Private Limited. This strategic move enhances Eris's portfolio and potentially opens up new avenues for growth in the healthcare sector, aligning with their long-term expansion goals. Investors should view this development positively as it may strengthen Eris's market position and diversify their offerings, signaling potential for future growth. Watch closely for any forthcoming initiatives or collaborations resulting from this acquisition that might further impact the company's performance.